Velpatasvir-d7 structure
|
Common Name | Velpatasvir-d7 | ||
---|---|---|---|---|
CAS Number | 2172676-02-5 | Molecular Weight | 890.04 | |
Density | N/A | Boiling Point | N/A | |
Molecular Formula | C49H47D7N8O8 | Melting Point | N/A | |
MSDS | N/A | Flash Point | N/A |
Use of Velpatasvir-d7Velpatasvir-d7 (GS-5816-d7) is the deuterium labeled Velpatasvir. Velpatasvir (GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 2.16 μM[2]. |
Name | Velpatasvir-d7 |
---|
Description | Velpatasvir-d7 (GS-5816-d7) is the deuterium labeled Velpatasvir. Velpatasvir (GS-5816) is a novel pan-genotypic hepatitis C virus (HCV) nonstructural protein 5A (NS5A) inhibitor with activity against genotype 1 (GT1) to GT6 HCV replicons. Velpatasvir is also a SARS-CoV 3CLpro inhibitor with an IC50 of 2.16 μM[2]. |
---|---|
Related Catalog | |
In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
References |
Molecular Formula | C49H47D7N8O8 |
---|---|
Molecular Weight | 890.04 |